In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin
about
Molecular and cellular aspects of calcific aortic valve diseaseRegulation of osteoblast development by Bcl-2-associated athanogene-1 (BAG-1)Bone Alkaline Phosphatase and Tartrate-Resistant Acid Phosphatase: Potential Co-regulators of Bone MineralizationTissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(-/-) mouse model of infantile hypophosphatasiaSex-dependent, zinc-induced dephosphorylation of phospholamban by tissue-nonspecific alkaline phosphatase in the cardiac sarcomereThe impairment of osteogenesis in bone sialoprotein (BSP) knockout calvaria cell cultures is cell density dependent.Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification.Enzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasia.Potency Biomarker Signature Genes from Multiparametric Osteogenesis Assays: Will cGMP Human Bone Marrow Mesenchymal Stromal Cells Make Bone?The Morphogenesis of Cranial Sutures in Zebrafish.Alkaline Phosphatase and Hypophosphatasia.Transgenic Overexpression of Tissue-Nonspecific Alkaline Phosphatase (TNAP) in Vascular Endothelium Results in Generalized Arterial Calcification.Nutrition in Cardioskeletal Health.Skeletal Mineralization Deficits and Impaired Biogenesis and Function of Chondrocyte-Derived Matrix Vesicles in Phospho1(-/-) and Phospho1/Pi t1 Double-Knockout Mice.Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.Ablation of osteopontin improves the skeletal phenotype of phospho1(-/-) mice.Increased osteopontin contributes to inhibition of bone mineralization in FGF23-deficient mice.Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling.MicroRNA-503-5p inhibits stretch-induced osteogenic differentiation and bone formation.Targeting osteopontin, the silent partner of Na+/H+ exchanger isoform 1 in cardiac remodeling.Tissue Nonspecific Alkaline Phosphatase (TNAP) Regulates Cranial Base Growth and Synchondrosis Maturation.Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis.Extracellular Phosphate Induces the Expression of Dentin Matrix Protein 1 Through the FGF Receptor in Osteoblasts.Fibroblast-like synoviocytes induce calcium mineral formation and depositionOverexpression of tissue-nonspecific alkaline phosphatase (TNAP) in endothelial cells accelerates coronary artery disease in a mouse model of familial hypercholesterolemia.FGF23 Regulates Bone Mineralization in a 1,25(OH)2 D3 and Klotho-Independent Manner.Osteopontin regulates dentin and alveolar bone development and mineralization.Mast Cell Mediators Inhibit Osteoblastic Differentiation and Extracellular Matrix Mineralization.Cell Phenotype Transitions in Cardiovascular Calcification.A GTPase-activating protein binding protein (G3BP1) / antiviral protein relay conveys arteriosclerotic Wnt signals in aortic smooth muscle cells.Osteogenesis imperfecta and therapeutics.Applied Pathology for Interventions of Coronary Chronic Total Occlusion.
P2860
Q27026105-6CC1A6F0-F0A7-47B7-83C8-D1017E523175Q28830055-99391577-9C3A-48DC-9176-7314A95ECE0AQ33841897-36B2420D-DA20-4604-949D-5FA7CA93406AQ34111540-020156B4-3912-4AB5-8342-360744B9F55AQ34201068-7F5DA9BD-A4B5-463F-9141-1C36F13DBD64Q35118585-C4F780AA-4C11-44B7-B076-907D91D2DDBFQ35525230-187451B9-065D-4795-90C3-853933166CD2Q35739074-AACB7622-D60E-4BC6-8807-6F64DF20147CQ36154881-F897BAF6-050C-49F9-A25D-A6E8BBC0D2B8Q36187381-7794E91A-8175-46D6-8FAF-6EF11CCEC078Q36778063-CC5BE307-1873-400A-BE14-80A2FE2BB0EDQ36836414-26018DA6-EB18-4CB9-9EC5-5D3D5EEC51E9Q36890341-A2E5BD54-1040-446C-B143-580F62955B6FQ36963577-E0B6D83A-4C1E-4BD4-BA79-D2663ED4F4E0Q37406418-ACDCA929-5ABD-438B-BCF4-C95A37FE4F70Q37594761-2941B09D-D4B5-4A8E-9410-8F20321F82D8Q37607946-1353CE54-CA76-494E-B10C-F09B3EF151AEQ38289071-D3C214DE-C6B5-4F92-AB40-FC27E3546656Q38290132-95E4C62C-30FA-45E3-BF17-E8A0F67D6993Q38354012-AEEB153F-38A5-42B1-B636-7A070B8135E6Q38404898-E97FC6F5-555F-4DFA-A8EF-E2A3280CDD89Q38693472-F2475718-92E3-4BF5-8B51-CFCD36428FE5Q38745833-F7AF5E8C-839E-4A87-B6B3-FC02E18B5E23Q40623957-9EF790A0-4587-46BF-B1FB-2942D9110F8EQ46274127-33C3C498-E20F-4CB7-9702-D6C3DD062305Q46280374-64C454D7-DFBA-4712-90F9-0861B76B7E85Q47192047-53DD8281-6013-4AAA-9EC8-A38C5A4245DEQ47693861-46595E64-8F58-4C37-AE7E-8673416B9099Q52597448-964A8DAB-DB27-4F26-9BE2-8912620359DDQ52601695-C9F519C6-1198-4A8A-879E-13A082D0E138Q52655586-618AF2EB-B353-4991-8DAD-85769FD16DEAQ54863191-94E0F460-E57B-4D29-9962-9E9872B129F8
P2860
In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
In vivo overexpression of tiss ...... rylation status of osteopontin
@en
type
label
In vivo overexpression of tiss ...... rylation status of osteopontin
@en
prefLabel
In vivo overexpression of tiss ...... rylation status of osteopontin
@en
P2093
P2860
P356
P1476
In vivo overexpression of tiss ...... rylation status of osteopontin
@en
P2093
José Luis Millán
Manisha C Yadav
Sonoko Narisawa
P2860
P304
P356
10.1002/JBMR.1901
P577
2013-07-01T00:00:00Z